← back to search

Thomas J. Montine

Stanford University · US
Area of research
Physiology · Neurology
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Parkinson's Disease Mechanisms and Treatments, and Neuroinflammation and Neurodegeneration Mechanisms.
h-index
115
citations
61,497
works
728
NIH funding
primary concept
Medicine
email

Recent publications

Enrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome
Nature Communications 2025cited by 44position: middledoi
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
JAMA 2025cited by 37position: middledoi
AI-guided precision parenteral nutrition for neonatal intensive care units
Nature Medicine 2025cited by 21position: middledoi
Spatial proteomics of Alzheimer’s disease-specific human microglial states
Nature Immunology 2025cited by 17position: middledoi
<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Brain Communications 2025cited by 15position: middledoi
Exposure to autoimmune disorders is associated with increased Alzheimer’s disease risk in a multi-site electronic health record analysis
Cell Reports Medicine 2025cited by 7position: middledoi
Epigenomic profile of GBA1 in Parkinson's disease
Parkinsonism & Related Disorders 2025cited by 1position: lastdoi
Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET
Acta Neuropathologica Communications 2025cited by 0position: middledoi
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
The Lancet Neurology 2024cited by 540position: middledoi
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
npj Parkinson s Disease 2024cited by 34position: middledoi
Mediterranean diet protects against a neuroinflammatory cortical transcriptome: Associations with brain volumetrics, peripheral inflammation, social isolation, and anxiety in nonhuman primates (Macaca fascicularis)
Brain Behavior and Immunity 2024cited by 27position: middledoi
Developing a Research Center for Artificial Intelligence in Medicine
Mayo Clinic Proceedings Digital Health 2024cited by 12position: middledoi
Exposure to autoimmune disorders increases Alzheimer’s disease risk in a multi-site electronic health record analysis
medRxiv 2024cited by 3position: middledoi
Effects of Mediterranean vs. Western Diets on the Cerebral Cortical Pre‐Synaptic Proteome in Nonhuman Primates
Alzheimer s & Dementia 2024cited by 0position: middledoi
Clonal hematopoiesis is associated with protection from Alzheimer’s disease
Nature Medicine 2023cited by 141position: middledoi
Mag-Net: Rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 63position: middledoi
Whole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
Nature Communications 2023cited by 23position: lastdoi
Spatial proteomics reveals human microglial states shaped by anatomy and neuropathology
Research Square 2023cited by 18position: middledoi
Prediction of neuropathologic lesions from clinical data
Alzheimer s & Dementia 2023cited by 16position: lastdoi
Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer’s Disease and Lewy Body Dementia in the Oldest Old: A Case Series
Journal of Alzheimer s Disease 2023cited by 13position: middledoi
Neuropathologic Changes of Alzheimer’s Disease and Related Dementias: Relevance to Future Prevention
Journal of Alzheimer s Disease 2023cited by 11position: lastdoi
Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study
Journal of Alzheimer s Disease 2023cited by 8position: middledoi
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier
Alzheimer Disease & Associated Disorders 2023cited by 5position: middledoi
LATE-NC staging in routine neuropathologic diagnosis: an update
Acta Neuropathologica 2022cited by 172position: middledoi
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Acta Neuropathologica 2022cited by 160position: middledoi
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Neuron 2022cited by 99position: middledoi
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Journal of Neuropathology & Experimental Neurology 2022cited by 47position: middledoi
Interpretable deep learning of myelin histopathology in age-related cognitive impairment
Acta Neuropathologica Communications 2022cited by 36position: middledoi
Methylation differences in Alzheimer’s disease neuropathologic change in the aged human brain
Acta Neuropathologica Communications 2022cited by 26position: lastdoi
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
Brain Research 2022cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brenna Cholerton · Palo Alto University14 papers (2014–2025)María M. Corrada · University of California, Irvine10 papers (2018–2025)Claudia H. Kawas · University of California, Irvine10 papers (2018–2025)Syed Bukhari · Palo Alto University9 papers (2022–2025)Suzanne Craft · National Center for Geriatrics and Gerontology9 papers (2013–2024)Joseph F. Quinn · Oregon Health & Science University8 papers (2014–2020)Cyrus P. Zabetian · University of Washington8 papers (2014–2020)John Q. Trojanowski · University of Pennsylvania8 papers (2012–2017)Lon R. White · Pacific Health Research and Education Institute7 papers (2018–2023)Nima Aghaeepour · Palo Alto University7 papers (2020–2025)C. Dirk Keene · Seattle Pacific University7 papers (2015–2025)James B. Leverenz · Cleveland Clinic7 papers (2014–2018)Kathleen L. Poston · Palo Alto University7 papers (2018–2025)Karen L. Edwards · Swansea Bay University Health Board6 papers (2014–2020)Kathryn A. Chung · IIT@MIT6 papers (2014–2020)M. Ryan Corces · Gladstone Institutes6 papers (2017–2025)Thanaphong Phongpreecha · Palo Alto University6 papers (2020–2025)Howard Y. Chang · Amgen (United States)6 papers (2017–2025)Thomas C. Register · University of Alabama at Birmingham5 papers (2018–2024)Steven D. Edland · University of California San Diego5 papers (2018–2019)